Hypoglycemic Agents: all 3,927 studies that test it

Page 9 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.

• Cellular Dynamics of Subcutaneous Fat Distribution in Obese WomenCompletedNCT01748994Not applicableResults posted
• Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01734785Phase 3Results posted
• Effects of Metformin on Hepatic FFA MetabolismCompletedNCT01729156Phase 4Results posted
• Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC TransplantCompletedNCT01720264Phase 2Results posted
• Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesCompletedNCT01719003Phase 3Results posted
• Metformin as a Chemoprevention Agent in Non-small Cell Lung CancerTerminatedNCT01717482Phase 2Results posted
• Pioglitazone for the Treatment of Bipolar DepressionTerminatedNCT01717040Phase 4Results posted
• A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime InsulinCompletedNCT01713530Phase 3Results posted
• BE Study of Metformin GSK 500mgCompletedNCT01710527Phase 2Results posted
• A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)CompletedNCT01709305Phase 4Results posted
• Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 PatientsCompletedNCT01708902Phase 3Results posted
• Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)CompletedNCT01703286Phase 1Results posted
• Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitisTerminatedNCT01703260Phase 2Results posted
• Point-of-Care Glucose Testing and Insulin SupplementationCompletedNCT01702311Not applicableResults posted
• A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)CompletedNCT01702298Phase 3Results posted
• A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive EfficiencyCompletedNCT01700387Phase 4Results posted
• An Endometrial Cancer Chemoprevention Study of MetforminCompletedNCT01697566Phase 3Results posted
• A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With EpilepsyCompletedNCT01689649Phase 4Results posted
• A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy ParticipantsCompletedNCT01688635Phase 1Results posted
• Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart FunctionCompletedNCT01686932Phase 4Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes MellitusCompletedNCT01683266Phase 3Results posted
• Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin GlargineCompletedNCT01680341Phase 3Results posted
• A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)TerminatedNCT01678820Phase 3Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic TherapyCompletedNCT01676220Phase 3Results posted
• Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single TabletsCompletedNCT01672788Phase 1Results posted
• Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic CancerCompletedNCT01666730Phase 2Results posted
• Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 DiabetesCompletedNCT01664624Phase 1Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedNCT01658579Phase 2Results posted
• Assessing the Behavior of Met DR in Subjects With Kidney DysfunctionCompletedNCT01658514Phase 2Results posted
• Pioglitazone in Thyroid CancersCompletedNCT01655719Phase 2Results posted
• Hyperglycemia in Renal TransplantationCompletedNCT01643382Not applicableResults posted
• Effects of Topiramate on Adolescent Alcohol Use: Efficacy and MechanismsCompletedNCT01641445Phase 1/2Results posted
• A Study of LY2963016 in Healthy ParticipantsCompletedNCT01634165Phase 1Results posted
• Effect of Metformin on Biomarkers of Colorectal Tumor Cell GrowthTerminatedNCT01632020Phase 2Results posted
• Role of Proinflammatory Signaling in Alcohol CravingTerminatedNCT01631630Phase 2Results posted
• Exemestane-RAD001-MetforminTerminatedNCT01627067Phase 2Results posted
• Cavitation Ultrasound in Treatment of Patients With PCOSCompletedNCT01622257Phase 2Results posted
• Effect of Apidra Compared to Humalog in Decreasing Post-Prandial HyperglycemiaCompletedNCT01621776Not applicableResults posted
• Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate CancerCompletedNCT01620593Phase 2Results posted
• Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 DiabetesCompletedNCT01618214Phase 4Results posted
• Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)CompletedNCT01614769Phase 1Results posted
• Humalog® Mix50/50(tm) as a Treatment for Gestational DiabetesCompletedNCT01613807Phase 4Results posted
• Metabolic Abnormalities in HIV-infected PersonsCompletedNCT01612858Phase 4Results posted
• Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 DiabeticsCompletedNCT01610154Phase 4Results posted
• A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes MellitusCompletedNCT01600950Phase 1Results posted
• Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in HumansCompletedNCT01600703Phase 2/3Results posted
• Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)CompletedNCT01595646Phase 2Results posted
• A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)CompletedNCT01590797Phase 3Results posted
• A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)CompletedNCT01590771Phase 3Results posted
• Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes PatientsCompletedNCT01589653Phase 4Results posted
• Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus SubjectsCompletedNCT01589445Phase 4Results posted
• Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)CompletedNCT01588470Phase 4Results posted
• A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)CompletedNCT01582308Phase 1Results posted
• Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus PatientsCompletedNCT01582243Phase 4Results posted
• Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single TabletsCompletedNCT01581931Phase 1Results posted
• The Childhood and Adolescent Migraine Prevention StudyTerminatedNCT01581281Phase 3Results posted
• Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic PatientsCompletedNCT01579812Phase 2Results posted
• Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.TerminatedNCT01578551Phase 2Results posted
• A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes)CompletedNCT01573949Not applicableResults posted
• A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose InsulinCompletedNCT01570751Phase 3Results posted
• Heart And Lung Failure - Pediatric INsulin Titration TrialCompletedNCT01565941Phase 3Results posted
• Cardiac Surgery Neuroprotection Study in EldersCompletedNCT01561378Phase 2Results posted
• Pioglitazone in Patients With Mood DisordersCompletedNCT01559857Phase 4Results posted
• A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)CompletedNCT01557504Phase 1Results posted
• Effectiveness of Sitagliptin for HIV Insulin Resistance and InflammationCompletedNCT01552694Phase 3Results posted
• Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)CompletedNCT01545388Phase 3Results posted
• Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /MetforminCompletedNCT01540487Phase 1Results posted
• Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2)CompletedNCT01537120Phase 1Results posted
• Effect of BIA 9-1067 on the Pharmacokinetics of RepaglinideCompletedNCT01536366Phase 1Results posted
• Sitagliptin Dose Determination StudyCompletedNCT01530178Phase 4Results posted
• Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected PatientsCompletedNCT01525628Phase 1Results posted
• Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DMTerminatedNCT01525225Phase 1Results posted
• Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and MetforminCompletedNCT01519674Phase 4Results posted
• Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on MetforminCompletedNCT01517412Phase 3Results posted
• A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT01513590Phase 3Results posted
• A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes MellitusCompletedNCT01513473Phase 3Results posted
• Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 DiabetesCompletedNCT01512979Phase 4Results posted
• Treatment of Diabetes After Gastric Bypass With SitagliptinCompletedNCT01512797Not applicableResults posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic TherapyCompletedNCT01499095Phase 3Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedNCT01499082Phase 3Results posted
• Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 DiabetesTerminatedNCT01486966Phase 4Results posted
• Metformin and Transient HyperglycemiaTerminatedNCT01486043Not applicableResults posted
• Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)CompletedNCT01485614Phase 3Results posted
• Physiologic Response to Glucagon at Varying Insulin LevelsCompletedNCT01483651Not applicableResults posted
• REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)CompletedNCT01483560Phase 3Results posted
• Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOSTerminatedNCT01482286Phase 3Results posted
• Simplified Insulin Protocol Using Lantus in ElderlyCompletedNCT01480843Phase 4Results posted
• A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)TerminatedNCT01477853Phase 3Results posted
• A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy ParticipantsCompletedNCT01476345Phase 1Results posted
• Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump TherapyCompletedNCT01474538Phase 3Results posted
• DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 DiabetesCompletedNCT01472432Phase 4Results posted
• Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260)CompletedNCT01462266Phase 3Results posted
• Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 DiabetesCompletedNCT01456130Phase 3Results posted
• Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes MellitusCompletedNCT01449747Phase 4Results posted
• Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett EsophagusCompletedNCT01447927Phase 2Results posted
• Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic ControlCompletedNCT01438814Phase 4Results posted
• Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.CompletedNCT01436045Phase 2Results posted
• Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing SurgeryCompletedNCT01433913Phase 2Results posted
• Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)CompletedNCT01431521Phase 1Results posted
• Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 DiabetesCompletedNCT01427920Phase 4Results posted

← Hypoglycemic Agents overview